Skip to main content

Beta Bionics, Inc. (BBNX) Stock Forecast 2025 - AI Price Prediction & Analysis


Beta Bionics, Inc. (BBNX) AI Stock Price Forecast & Investment Analysis

Beta Bionics, Inc. Stock Price Chart and Technical Analysis

Loading Beta Bionics, Inc. interactive price chart and technical analysis...

Beta Bionics, Inc. (BBNX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Beta Bionics, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Beta Bionics, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Beta Bionics, Inc.: Beta Bionics, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Beta Bionics, Inc. (Stock Symbol: BBNX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Beta Bionics, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Beta Bionics, Inc.:

Market Capitalization: $870 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Beta Bionics, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Beta Bionics, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Beta Bionics, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Beta Bionics, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Beta Bionics, Inc.: Market positioning analysis based on available financial and operational metrics.

Beta Bionics, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Beta Bionics, Inc. (BBNX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Beta Bionics, Inc. stock analysis.

Loading Beta Bionics, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Beta Bionics, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Beta Bionics, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Beta Bionics, Inc.:

P/B Ratio 2.88x
Market Cap $870M
Book Value/Share $6.94
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Beta Bionics, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Beta Bionics, Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Beta Bionics, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Beta Bionics, Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Beta Bionics, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Beta Bionics, Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Beta Bionics, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Beta Bionics, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Beta Bionics, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Beta Bionics, Inc.:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 43M

Latest Beta Bionics, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Beta Bionics, Inc. (BBNX) stock price and investment outlook.

, source: Eagle-Tribune

IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced ...

Beta Bionics, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Beta Bionics, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $21M x 2.4x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $478M -1.4x 2.7x
ANIK Unlock Forecast - 30 Days FREE Trial $132M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1867M -198.2x 4.5x
APYX Unlock Forecast - 30 Days FREE Trial $110M -3.5x 15.2x
ATEC Unlock Forecast - 30 Days FREE Trial $2152M -7.4x 90.5x
ATRC Unlock Forecast - 30 Days FREE Trial $1857M -39.6x 4.0x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $11807M -94.9x 1.6x
BBNX Unlock Forecast - 30 Days FREE Trial $870M x 2.9x
BDX Unlock Forecast - 30 Days FREE Trial $53486M 33.7x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $58M -5.7x 13.9x
BJDX Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.7x
BSX Unlock Forecast - 30 Days FREE Trial $146015M 58.3x 6.5x
BVS Unlock Forecast - 30 Days FREE Trial $458M -18.3x 2.8x
CARL Unlock Forecast - 30 Days FREE Trial $62M x x
CLPT Unlock Forecast - 30 Days FREE Trial $721M -23.5x 36.5x
CODX Unlock Forecast - 30 Days FREE Trial $12M -0.7x 0.3x
CVRX Unlock Forecast - 30 Days FREE Trial $260M -5.5x 4.5x
DCTH Unlock Forecast - 30 Days FREE Trial $418M 187.5x 4.0x
DRTS Unlock Forecast - 30 Days FREE Trial $319M x 3.7x
DXCM Unlock Forecast - 30 Days FREE Trial $26015M 45.5x 10.1x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $7M x 12.7x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $4885M -46.3x 6.4x
GMED Unlock Forecast - 30 Days FREE Trial $8091M 22.7x 1.9x
HRGN Unlock Forecast - 30 Days FREE Trial $29M x 38.2x
IART Unlock Forecast - 30 Days FREE Trial $1128M 200.2x 1.1x
ICCM Unlock Forecast - 30 Days FREE Trial $48M x 16.6x
ICUI Unlock Forecast - 30 Days FREE Trial $2926M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $27M x 6.2x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.5x
INFU Unlock Forecast - 30 Days FREE Trial $184M 36.2x 3.4x
INSP Unlock Forecast - 30 Days FREE Trial $2310M 43.5x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $929M 45.0x 9.9x
IRTC Unlock Forecast - 30 Days FREE Trial $5812M -20.2x 56.1x
KIDS Unlock Forecast - 30 Days FREE Trial $402M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1196M x x
KRMD Unlock Forecast - 30 Days FREE Trial $187M -19.8x 11.3x
LNSR Unlock Forecast - 30 Days FREE Trial $141M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $120M -0.6x 15.3x
LUNG Unlock Forecast - 30 Days FREE Trial $62M -4.3x 0.9x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $970M 30.2x 4.5x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $80645M 20.5x 18.8x
MMSI Unlock Forecast - 30 Days FREE Trial $4785M 40.2x 3.2x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $41M -1.7x 5.0x
NPCE Unlock Forecast - 30 Days FREE Trial $344M -10.4x 17.7x
NSPR Unlock Forecast - 30 Days FREE Trial $76M -4.3x 3.7x
NVCR Unlock Forecast - 30 Days FREE Trial $1531M -20.8x 4.4x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $128M -3.4x 1.3x
OFIX Unlock Forecast - 30 Days FREE Trial $595M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
OSUR Unlock Forecast - 30 Days FREE Trial $223M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $86M 9.5x 2.3x
PEN Unlock Forecast - 30 Days FREE Trial $9954M 67.4x 7.7x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PMI Unlock Forecast - 30 Days FREE Trial $90M x x
PODD Unlock Forecast - 30 Days FREE Trial $22506M 95.3x 15.4x
PRCT Unlock Forecast - 30 Days FREE Trial $1877M -45.4x 4.9x
PROF Unlock Forecast - 30 Days FREE Trial $166M x 4.2x
PYPD Unlock Forecast - 30 Days FREE Trial $51M x 2.5x
RCEL Unlock Forecast - 30 Days FREE Trial $106M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $35M x 13.0x
RMD Unlock Forecast - 30 Days FREE Trial $39524M 28.2x 6.6x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $244M -3.7x 3.5x
SIBN Unlock Forecast - 30 Days FREE Trial $634M -14.3x 3.7x
SKIN Unlock Forecast - 30 Days FREE Trial $181M -1.8x 2.5x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $291M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12387M 32.6x 3.4x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $8M -8.0x 25.6x
STIM Unlock Forecast - 30 Days FREE Trial $178M -1.0x 6.6x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $142678M 48.9x 12.2x
TCMD Unlock Forecast - 30 Days FREE Trial $324M 21.4x 1.7x
TELA Unlock Forecast - 30 Days FREE Trial $61M -1.8x 6.6x
TFX Unlock Forecast - 30 Days FREE Trial $5589M 29.1x 1.3x
TNDM Unlock Forecast - 30 Days FREE Trial $999M -17.1x 7.5x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $191M 15.2x 1.6x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $19211M 39.4x 6.6x
XTNT Unlock Forecast - 30 Days FREE Trial $99M -478.8x 2.0x

Frequently Asked Questions - Beta Bionics, Inc. Stock Forecast

How accurate are Beta Bionics, Inc. stock predictions?

Our AI model demonstrates 33% historical accuracy for BBNX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Beta Bionics, Inc. stock price forecasts?

Our analysis considers Beta Bionics, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Beta Bionics, Inc. a good investment in 2025?

Based on our AI analysis, Beta Bionics, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Beta Bionics, Inc. forecasts updated?

Beta Bionics, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Beta Bionics, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Beta Bionics, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...